Cannabinoid control of olfactory processes: The where matters
dc.rights.license | open | en_US |
hal.structure.identifier | Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB] | |
dc.contributor.author | TERRAL, Geoffrey | |
hal.structure.identifier | Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB] | |
dc.contributor.author | MARSICANO, Giovanni | |
dc.contributor.author | GRANDES, Pedro | |
hal.structure.identifier | Ikerbasque - Basque Foundation for Science | |
dc.contributor.author | SORIA-GOMEZ, Edgar | |
dc.date.accessioned | 2023-06-06T08:38:22Z | |
dc.date.available | 2023-06-06T08:38:22Z | |
dc.date.issued | 2020-04-16 | |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/182497 | |
dc.description.abstractEn | Olfaction has a direct influence on behavior and cognitive processes. There are different neuromodulatory systems in olfactory circuits that control the sensory information flowing through the rest of the brain. The presence of the cannabinoid type-1 (CB1) receptor, (the main cannabinoid receptor in the brain), has been shown for more than 20 years in different brain olfactory areas. However, only over the last decade have we started to know the specific cellular mechanisms that link cannabinoid signaling to olfactory processing and the control of behavior. In this review, we aim to summarize and discuss our current knowledge about the presence of CB1 receptors, and the function of the endocannabinoid system in the regulation of different olfactory brain circuits and related behaviors. © 2020 by the authors. Licensee MDPI, Basel, Switzerland. | |
dc.language.iso | EN | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | Olfaction | |
dc.subject | Endocannabinoids | |
dc.subject | Olfactory epithelium | |
dc.subject | Olfactory bulb | |
dc.subject | Piriform cortex | |
dc.subject | Cb1 receptor | |
dc.title.en | Cannabinoid control of olfactory processes: The where matters | |
dc.title.alternative | Genes | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.3390/genes11040431 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC] | en_US |
dc.identifier.pubmed | 32316252 | en_US |
dc.description.sponsorshipEurope | Neurocircuitry of endocannabinoid regulation of food intake | en_US |
dc.description.sponsorshipEurope | Development of pregnenolone derivatives as allosteric inhibitors of CB1 cannabinoid receptors for thetreatment of schizophrenia and psychotic syndromes | en_US |
bordeaux.journal | Genes | en_US |
bordeaux.volume | 11 | en_US |
bordeaux.hal.laboratories | Neurocentre Magendie - U1215 | en_US |
bordeaux.issue | 4 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.institution | INSERM | en_US |
bordeaux.institution | CNRS | |
bordeaux.team | Endocannabinoïdes et Neuroadaptation | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
bordeaux.identifier.funderID | Fondation pour la Recherche Médicale | en_US |
bordeaux.identifier.funderID | Ikerbasque, Basque Foundation for Science | en_US |
bordeaux.identifier.funderID | Instituto de Salud Carlos III | en_US |
bordeaux.identifier.funderID | European Regional Development Fund | en_US |
bordeaux.identifier.funderID | European Research Council | en_US |
bordeaux.identifier.funderID | H2020 European Research Council | en_US |
bordeaux.identifier.funderID | Ministerio de Economía y Competitividad | en_US |
hal.identifier | hal-04118424 | |
hal.version | 1 | |
hal.date.transferred | 2023-06-06T08:38:25Z | |
hal.export | true | |
dc.rights.cc | CC BY | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Genes&rft.date=2020-04-16&rft.volume=11&rft.issue=4&rft.au=TERRAL,%20Geoffrey&MARSICANO,%20Giovanni&GRANDES,%20Pedro&SORIA-GOMEZ,%20Edgar&rft.genre=article |